7018-17-9

Usage

Chemical structure

A complex chemical compound with a fluorine-substituted benzothiazole ring, a phenylpyrrolidine-2,3-dione core, and a hydroxyphenylmethylidene group.

Molecular weight

Approximately 435.49 g/mol

Pharmacological activity

Potential anti-inflammatory, antifungal, or antibacterial properties due to the presence of specific chemical groups.

Solubility

The solubility of 1-(6-fluoro-1,3-benzothiazol-2-yl)-4-[hydroxy(3-propoxyphenyl)methylidene]-5-phenylpyrrolidine-2,3-dione would need to be experimentally determined, but it may be soluble in organic solvents like dimethyl sulfoxide (DMSO) or methanol.

Stability

The stability of 1-(6-fluoro-1,3-benzothiazol-2-yl)-4-[hydroxy(3-propoxyphenyl)methylidene]-5-phenylpyrrolidine-2,3-dione under various conditions (e.g., temperature, pH, light exposure) would need to be studied to determine its shelf life and appropriate storage conditions.

Synthesis

The synthesis of 1-(6-fluoro-1,3-benzothiazol-2-yl)-4-[hydroxy(3-propoxyphenyl)methylidene]-5-phenylpyrrolidine-2,3-dione would involve multiple steps, including the formation of the benzothiazole ring, the phenylpyrrolidine-2,3-dione core, and the hydroxyphenylmethylidene group. The specific synthetic route would need to be optimized for yield and purity.

Analytical techniques

Techniques such as nuclear magnetic resonance (NMR) spectroscopy, mass spectrometry (MS), and infrared (IR) spectroscopy could be used to analyze and confirm the structure of 1-(6-fluoro-1,3-benzothiazol-2-yl)-4-[hydroxy(3-propoxyphenyl)methylidene]-5-phenylpyrrolidine-2,3-dione.

Biological activity

Further in vitro and in vivo studies would be required to determine the specific biological activities, target receptors, and potential therapeutic applications of 1-(6-fluoro-1,3-benzothiazol-2-yl)-4-[hydroxy(3-propoxyphenyl)methylidene]-5-phenylpyrrolidine-2,3-dione.

Toxicity

The toxicity profile of 1-(6-fluoro-1,3-benzothiazol-2-yl)-4-[hydroxy(3-propoxyphenyl)methylidene]-5-phenylpyrrolidine-2,3-dione would need to be evaluated through in vitro and in vivo assays to determine its safety for potential pharmaceutical applications.

Drug metabolism and pharmacokinetics

Studies on the absorption, distribution, metabolism, and excretion (ADME) properties of 1-(6-fluoro-1,3-benzothiazol-2-yl)-4-[hydroxy(3-propoxyphenyl)methylidene]-5-phenylpyrrolidine-2,3-dione would be necessary to understand its pharmacokinetic profile and potential for drug-drug interactions.

Synthesis scale-up

If the compound shows promising pharmacological activity, further research would be needed to optimize the synthetic route and scale-up the production for larger quantities.

Clinical trials

If the compound demonstrates potential therapeutic benefits and acceptable safety profiles in preclinical studies, clinical trials would be required to evaluate its efficacy and safety in humans.